Related Experiment Video
Updated: Jun 25, 2026

Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
Published on: July 23, 2016
Systemic siRNA delivery to leukocyte-implicated diseases.
1Department of Cell Research and Immunology, Laboratory for Nanomedicine, George S Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel. peer@post.tau.ac.il
Short interfering RNA (siRNA) holds therapeutic promise, but effective systemic delivery remains a challenge. This review highlights novel strategies targeting leukocytes for siRNA delivery and validating anti-inflammatory targets.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Short interfering RNA (siRNA) is a valuable research tool for gene function studies.
- Systemic delivery of siRNA for therapeutic applications is hindered by inefficient delivery methods.
- Leukocyte delivery of siRNA presents unique challenges due to a lack of effective technologies.
Purpose of the Study:
- To review recent advances in siRNA delivery strategies for systemic administration.
- To focus on novel platforms targeting leukocytes for enhanced siRNA delivery.
- To discuss the in vivo validation of anti-inflammatory targets using siRNA delivery systems.
Main Methods:
- Review of current literature on siRNA delivery systems.
- Discussion of novel platforms utilizing leukocyte integrins as targets.
- Case study on in vivo drug target validation for inflammatory bowel diseases.
Main Results:
- Development of new delivery strategies for targeted siRNA delivery.
- Identification of leukocyte integrins as viable targets for siRNA delivery.
- Successful in vivo validation of cyclin D1 as an anti-inflammatory target for IBD.
Conclusions:
- Novel siRNA delivery strategies show promise for therapeutic applications.
- Targeting leukocyte integrins offers a viable approach for siRNA delivery to immune cells.
- siRNA-based drug target validation is effective for inflammatory diseases.
More Related Videos
15:55Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy
Published on: June 21, 2013
09:36Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo
Published on: February 5, 2019
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...